Clinical Trial Update: A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma [Phase 2]

View source ↗

Summary

Phase II trial update evaluating TroVax in combination with chemotherapy for malignant pleural mesothelioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• TroVax

Snippet

Sponsor: Wales Cancer Trials Unit | Conditions: Malignant, Pleural | Phase 2 | Status: UNKNOWN